| Patents for C07K - Peptides (3,738) |
|---|
| 09/26/2001 | EP1135408A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| 09/26/2001 | CN1071760C N-terminally chemically modified protein composition and methods |
| 09/20/2001 | WO2001068710A1 Monoclonal antibodies to the human ldl receptor, their production and use |
| 09/20/2001 | WO2000037490A3 Outer surface proteins, their genes, and their use |
| 09/19/2001 | CN1313343A N-terminal modified protein compositions and methods therefor |
| 09/18/2001 | US6291649 Anti-bodies binding adhesin-derived antigens |
| 09/18/2001 | US6290969 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 09/13/2001 | WO2001066573A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 09/12/2001 | CN1312724A TNF-drvived peptides of use in treating oedema |
| 09/11/2001 | US6287574 Proteinase K resistant surface protein of neisseria meningitidis |
| 09/05/2001 | CN1311818A Neurotrophic factors |
| 09/05/2001 | CN1311797A Process for producing immunolobulins for intravenous administration and other immunolobulin products |
| 09/04/2001 | US6284884 Depolymerization and reacting with base to form de-n-acetylated polysaccharide; reacting with nitrosation agent |
| 08/30/2001 | WO2001062801A2 Humanized antibodies that sequester amyloid beta peptide |
| 08/29/2001 | EP1127893A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/28/2001 | US6281336 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 08/28/2001 | US6280975 Adjusted interleukin polypeptide for use in the treatment of myelomas, tumors, osteoporosis and autoimmune diseases |
| 08/23/2001 | WO2001000842A3 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 08/21/2001 | US6277828 Aqueous isotonic solutions containing human serum albumin, sodium chloride and citric acid, suitable for lyophilization, useful for the treatment of alzheimer's disease |
| 08/21/2001 | CA2121889C Production and use of multimeric hemoglobins |
| 08/15/2001 | CN1308674A Multivalent T cell receptor complexes |
| 08/14/2001 | US6274331 Using recombinant dna vectors which encode di-alpha or di-beta globin-like polypeptide having linker, transforming cells, screening for production by determining response to carbon monoxide, determining amino acid sequence of linker |
| 08/02/2001 | WO2001055178A2 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | WO2001000804A3 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 08/02/2001 | CA2395832A1 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/01/2001 | CN1306572A Soluble T cell receptor |
| 08/01/2001 | CN1306007A Dry cell factor |
| 07/31/2001 | US6268346 Having high biological activity of the same type as the known natural compound bpc, but with shorter amino acid chains. |
| 07/19/2001 | WO2001005820A3 Method for down-regulating gdf-8 activity |
| 07/19/2001 | WO2001000844A3 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 07/18/2001 | EP1115874A2 Alzheimer's disease secretase |
| 07/18/2001 | EP1115849A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 07/17/2001 | US6262028 CONTAINING OXY-SUBSTITUTED AMIDINOBENZYL DERIVATIVES OF DIPEPTIDES FROM CYCLOHEXYLGLYCINE AND AZETIDINE-2-CARBOXYLIC ACID; ximelagatran |
| 07/17/2001 | US6261559 Inhalation device |
| 07/12/2001 | US20010007662 Aqueous formulation suitable for lyophilization; biologically active form of nerve growth factor with bulking agent, buffer and water |
| 07/11/2001 | EP1114863A2 Heregulins (HRGs), binding proteins of P185erb2 |
| 07/04/2001 | EP1112090A2 Method of stimulating prosaposin receptor activity |
| 06/21/2001 | WO2001044291A2 Polynucleotid encoding the rg1 polypeptide |
| 06/21/2001 | CA2394574A1 Dna encoding a novel rg1 polypeptide |
| 06/20/2001 | CN1299973A HCV-free-blood external preparing method |
| 06/19/2001 | US6248516 Library for expression of immunoglobulin heavy chain variable domains |
| 06/13/2001 | EP1106606A2 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
| 06/13/2001 | EP1105152A1 Tnf-derived peptides for use in treating oedema |
| 05/30/2001 | EP0859785B1 Cyclic peptide analogs of somatostatin |
| 05/30/2001 | CN1066345C Growth hormone releasing factor analogs |
| 05/25/2001 | WO2001036471A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/25/2001 | CA2390547A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/02/2001 | EP1095145A1 Pathogen-resistant grape plants |
| 05/02/2001 | EP1095140A2 Neurotrophic factors |
| 04/24/2001 | US6221376 Glial cell line-derived neurotrophic factor |
| 04/24/2001 | CA2220055C Dipeptides which promote release of growth hormone |
| 04/24/2001 | CA2135277C Anti-receptor agents to the vitamin b12/transcobalamin ii receptor |
| 04/18/2001 | CN1292029A Compounds for therapy and diagnosis for lung cancer and method for their use |
| 04/18/2001 | CN1064710C Therapeutic uses of keratinocyte growth factor |
| 04/17/2001 | US6218148 DNS encoding stem cell factor |
| 04/17/2001 | CA2052323C Oligosaccharide conjugate vaccines |
| 04/05/2001 | WO2001023410A2 Drug target isogenes: polymorphisms in the interleukin 13 gene |
| 04/03/2001 | US6211151 Peptides with organo-protective activity, a process for preparation thereof and their use in therapy |
| 03/29/2001 | WO2001000843A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 03/28/2001 | CN1063796C Preparation method for drythropoietin isoforms |
| 03/27/2001 | US6207802 Non-human, mammalian polypeptide of defined amino acid sequence which activates the growth of early hematopoietic progenitor cells; treatment of blood disorders; anticarcinogenic agents; bone marrow regeneration |
| 03/27/2001 | US6207417 DNA encoding stem cell factor |
| 03/21/2001 | EP1084147A1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 03/07/2001 | EP1080193A2 Multivalent t cell receptor complexes |
| 02/28/2001 | CN1285514A Medicine box bof testing anti-hepatitis C virus antibody |
| 02/27/2001 | US6194383 Homologous cyclic amino-acid sequences having different fatty acid residues synthesized by actinoplanes sp.; peptide antibiotics, lipopeptides a 1437, a-m, effective against grampositive bacteria and glycopeptide-resistant strains |
| 02/21/2001 | EP1076703A2 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/21/2001 | EP0784683B1 Tie-2 ligands, methods of making and uses thereof |
| 02/20/2001 | CA2076749C Vasoactive vasotocin derivatives |
| 02/14/2001 | EP1076066A1 Peptides for lowering blood glucose levels |
| 02/06/2001 | US6184200 Truncated glial cell line-derived neurotrophic factor |
| 01/31/2001 | CN1282422A Determination of cellular growth abnormality |
| 01/25/2001 | WO2001005820A2 Method for down-regulating gdf-8 activity |
| 01/25/2001 | CA2379852A1 Method for down-regulating gdf-8 activity |
| 01/24/2001 | CN1281466A Aggregates of human insulin derivatives |
| 01/18/2001 | WO2001004156A1 Peptides that lower blood glucose levels |
| 01/18/2001 | CA2680437A1 Peptides that lower blood glucose levels |
| 01/11/2001 | WO2001002578A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 01/11/2001 | CA2378153A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 01/10/2001 | EP1066380A2 Soluble t cell receptor |
| 01/09/2001 | US6172038 Antipathogenic peptides and compositions comprising them |
| 01/04/2001 | WO2001000844A2 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 01/04/2001 | WO2001000843A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 01/04/2001 | WO2001000842A2 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 01/04/2001 | WO2001000805A2 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 01/04/2001 | WO2001000804A2 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 01/04/2001 | CA2383875A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 01/04/2001 | CA2383865A1 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 01/04/2001 | CA2380871A1 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 01/04/2001 | CA2380870A1 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 01/04/2001 | CA2380863A1 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 12/28/2000 | WO2000017369B1 Alzheimer's disease secretase |
| 12/26/2000 | US6166185 Antibodies to human TIE-2 ligands |
| 11/23/2000 | WO2000070054A1 Pathogen-resistant grape plants |
| 11/23/2000 | WO2000017369A3 Alzheimer's disease secretase |
| 11/16/2000 | WO2000034331A3 Analogues of glp-1 |
| 11/16/2000 | CA2369605A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 11/15/2000 | EP1051489A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 11/08/2000 | CN1272499A Method for preparing N-[5-(diphenyl phosphinyl methyl)-4-(4-fluoropheyl)-6-isopropyl pyrimidine-2-group]-N-methl methane sulfamide |
| 11/07/2000 | CA2075711C Vaccine and method therefor |